文献速递复苏、休克与脓毒症消化、代谢与肾脏急症重症综合管理与镇静镇痛

血必净注射液对脓毒症大鼠内皮微粒及肾皮质微循环的影响

[Effect of Xuebijing injection on endothelial microparticles and renal cortical microcirculation in septic rats].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2021-01-01
一句话结论脓毒症大鼠模型中,血必净作为抗生素辅助治疗可抑制血浆内皮微粒升高、改善肾皮质微循环并减轻肾损伤。

该研究将8~10周龄SPF雄性SD大鼠随机分为假手术组、阳性药物对照组和血必净组,每组10只,采用结扎75%盲肠的盲肠结扎穿孔术(CLP)制备重度脓毒症模型。建模后即刻经尾静脉给予血必净注射液(4 mL/kg,每12小时1次)联合亚胺培南/西司他丁(90 mg/kg,每6小时1次),阳性药物对照组给予生理盐水与亚胺培南/西司他丁,假手术组给予等量生理盐水。48小时后血必净组肾皮质灌注血管密度(PVD)和微血管血流指数(MFI)显著高于阳性药物对照组,血浆内皮微粒(EMP)显著低于对照组,血乳酸、Paller评分和血肌酐显著低于对照组,肾皮质缺氧探针阳性表达显著降低;EMP与PVD、MFI呈显著负相关。作者认为血必净作为抗生素辅助治疗可抑制脓毒症大鼠血浆EMP表达、改善肾皮质微循环并减轻肾损伤。

要点

  • 血必净组PVD(mm/mm²)16.20±1.20 vs 阳性药物对照组9.77±1.12,MFI 2.46±0.05 vs 1.85±0.15,均P<0.05。
  • 血必净组血乳酸(mmol/L)4.81±1.23 vs 阳性药物对照组6.08±1.09,P<0.05;MAP(mmHg)84.00±2.00 vs 80.00±2.00,P>0.05。
  • 血必净组血浆EMP(×10⁶/L)3.49±0.17 vs 阳性药物对照组5.78±0.22,P<0.05;EMP与PVD、MFI负相关(r分别为-0.94和-0.95,均P<0.05)。
  • 血必净组肾皮质缺氧探针阳性表达(35.89±1.13)% vs 阳性药物对照组(44.93±1.37)%,P<0.05。
  • 血必净组Paller评分46.90±3.84 vs 阳性药物对照组62.70±3.05,血肌酐(μmol/L)121.1±12.4 vs 192.7±23.9,均P<0.05。

适用人群与场景

  • 8~10周龄SPF级雄性SD大鼠,采用结扎75%盲肠的盲肠结扎穿孔术(CLP)制备重度脓毒症模型。
  • 假手术组仅牵拉盲肠、不结扎不穿孔。

处置流程与药物剂量

  • 血必净组于建模后即刻经尾静脉给予血必净注射液4 mL/kg、每12小时1次,联合亚胺培南/西司他丁90 mg/kg、每6小时1次。
  • 阳性药物对照组经尾静脉给予生理盐水与亚胺培南/西司他丁,给药方法同血必净组。
  • 假手术组给予与另两组中任一组等量、同频次的生理盐水。
  • 建模后48小时测定MAP、血乳酸,用旁流暗视野成像监测肾皮质微循环,氯化哌莫硝唑免疫组化评估肾缺氧信号,流式细胞术测血浆EMP,并测血肌酐、行Paller评分。

研究设计与关键结果

  • 研究类型为动物实验,SD大鼠随机分为假手术组、阳性药物对照组和血必净组,每组10只。
  • 与假手术组比较,阳性药物对照组和血必净组PVD、MFI及MAP显著下降,缺氧探针(哌莫硝唑)阳性表达增加,血乳酸、EMP、Paller评分和血肌酐显著升高。
  • 与阳性药物对照组比较,血必净组肾皮质微循环显著改善:PVD(mm/mm²)16.20±1.20 vs 9.77±1.12、MFI 2.46±0.05 vs 1.85±0.15,均P<0.05;血乳酸(mmol/L)4.81±1.23 vs 6.08±1.09,P<0.05;MAP(mmHg)84.00±2.00 vs 80.00±2.00,P>0.05。
  • 血必净组肾皮质哌莫硝唑阳性表达(35.89±1.13)% vs 阳性药物对照组(44.93±1.37)%,P<0.05。
  • 血必净组血浆EMP(×10⁶/L)3.49±0.17 vs 阳性药物对照组5.78±0.22,P<0.05;EMP与PVD、MFI显著负相关(r分别为-0.94和-0.95,均P<0.05)。
  • 血必净组Paller评分46.90±3.84 vs 阳性药物对照组62.70±3.05,血肌酐(μmol/L)121.1±12.4 vs 192.7±23.9,均P<0.05。

证据类型、等级与局限

  • 证据类型:动物实验(大鼠重度脓毒症模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,血必净注射液作为抗生素辅助治疗可抑制脓毒症大鼠血浆EMP表达、改善肾皮质微循环、减轻肾损伤,且该微循环改善作用不依赖MAP变化。
  • 上述结果来自大鼠重度脓毒症模型,原文未据此给出临床推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To clarify the characteristics of renal cortical microcirculation and its relationship with the expression of plasma endothelial microparticle (EMP) in septic rats, and to evaluate the effect of Xuebijing injection as an adjuvant therapy of antibiotics on septic AKI.

METHODS: The 8-10 weeks old specific pathogen free (SPF) male Sprague-Dawley (SD) rats were divided into sham operation group (Sham group), positive drug control group and Xuebijing group by the random number table method, with 10 rats in each group. The cecal ligation and puncture (CLP) with large ligation (ligated 75% of the cecum) was used to prepare a rat high-grade sepsis model; in the Sham group, the cecum was stretched without ligation or puncture. Due to the high mortality of CLP with large ligation, Xuebijing injection (4 mL/kg, 12 hours per time) and imipenem/cilastatin injection (90 mg/kg, 6 hours per time) were administered to the rats in the Xuebijing group via the tail vein immediately after the model was produced. Normal saline and imipenem/cilastatin were administered to the rats by the same methods in the positive drug control group. The rats in the Sham group were treated with the same volume of normal saline as any of the other two groups at the same frequency. At 48 hours after model reproduction, the mean arterial pressure (MAP) and blood lactic acid (Lac) of the rats were measured. The renal cortical microcirculation was monitored by using side stream dark-field imaging. Renal hypoxia signals were assessed by pimonidazole chloride immunohistochemistry. Plasma EMP levels were determined by using flow cytometry, and then the correlation between EMP and microcirculation parameters of renal cortex was analyzed. At the same time, the serum creatinine (SCr) was measured, and the renal injury score (Paller score) was used to evaluate the severity of renal tissue pathological damage.

RESULTS: Compared with the Sham group, perfused vessel density (PVD), microvascular flow index (MFI) and MAP in the positive drug control group and the Xuebijing group decreased significantly, the positive expression of hypoxia probe (pimonidazole) increased, Lac, EMP, Paller score and SCr increased significantly. However, compared with the positive drug control group, the renal cortical microcirculation in the Xuebijing group was improved significantly, PVD and MFI were increased significantly [PVD (mm/mm2): 16.20±1.20 vs. 9.77±1.12, MFI: 2.46±0.05 vs. 1.85±0.15, both P < 0.05], Lac was reduced significantly (mmol/L: 4.81±1.23 vs. 6.08±1.09, P < 0.05), MAP increased slightly [mmHg (1 mmHg = 0.133 kPa): 84.00±2.00 vs. 80.00±2.00, P > 0.05], suggested that Xuebijing injection improved renal microcirculation perfusion in septic rats, and this effect did not depend on the change of MAP. The positive expression of pemonidazole in renal cortex of the Xuebijing group was significantly lower than that of the positive drug control group [(35.89±1.13)% vs. (44.93±1.37) %, P < 0.05], suggested that Xuebijing injection alleviated renal hypoxia. The plasma EMP levels of rats in the Xuebijing group were significantly lower than those in the positive drug control group (×106/L: 3.49±0.17 vs. 5.78±0.22, P < 0.05), and the EMP levels were significantly negatively correlated with PVD and MFI (r values were -0.94 and -0.95, respectively, both P < 0.05), indicated that the increase of plasma EMP was highly correlated with renal microcirculation disorder, and Xuebijing injection inhibited the increase of plasma EMP levels. The Paller score in the Xuebijing group was significantly lower than that in the positive drug control group (46.90±3.84 vs. 62.70±3.05, P < 0.05), and the level of SCr was also significantly lower than that in the positive drug control group (μmol/L: 121.1±12.4 vs. 192.7±23.9, P < 0.05), which suggested that Xuebijing injection relieved kidney injury and improved renal function in septic rats.

CONCLUSIONS: As an adjuvant therapy of antibiotics, Xuebijing injection could inhibit the expression of plasma EMP in rats with sepsis, improve renal cortex microcirculation, and reduce kidney injury.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Liu J, Wang Z, Li T, et al. [Effect of Xuebijing injection on endothelial microparticles and renal cortical microcirculation in septic rats]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34955129. doi:10.3760/cma.j.cn121430-20210302-00318

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。